To assess the neuroprotective effect of PARP-1 knockdown on Aβ-induced neurotoxicity, we extended our analysis to a different transgenic AD model expressing the human amyloid precursor (APP695) protein and the β-secretase enzyme BACE1 within the central nervous system. The gene discussed is PARP1; the disease is Alzheimer disease.